Fletcher Payne

Fletcher Payne has extensive experience in the biotech industry, with a focus on financial management and strategic planning. Fletcher is currently the SVP CFO at Aptose Biosciences, Inc. Prior to this, they served as the Chief Financial Officer at Syapse, where they played a key role in raising capital and scaling operations globally. Fletcher has also worked as a Consulting CFO at CFP Advisory, providing financial consulting services to venture capital-backed companies in the life sciences sector. Fletcher served as CFO at both Catalyst Biosciences and CytomX Therapeutics, where they were responsible for raising funds and preparing the companies for IPOs. Earlier in their career, Fletcher held CFO positions at Pathwork Diagnostics, Plexxikon Inc., and Rinat Neuroscience. Fletcher has also worked as a Controller at Dynavax Technologies and as the Director of Finance and Assistant Treasurer at Cell Genesys, where they played a part in the successful spin-off and IPO of subsidiary Abgenix. Fletcher's expertise lies in strategic financial planning, business performance evaluation, and securing funding for biotech companies.

Fletcher Payne's education history includes two significant experiences. Firstly, they attended the University of California, Berkeley, Haas School of Business from 1984 to 1986, where they earned a Bachelor's degree in Finance & Accounting. Secondly, they participated in the University of Californian Berkeley Executive Education - BioExec Institute until 2011, although the specific degree and field of study are not mentioned.